- Tytuł :
- A randomised, single-blind, placebo-controlled, dose-finding safety and tolerability study of the anti-CD3 monoclonal antibody otelixizumab in new-onset type 1 diabetes
- Autorzy :
- Źródło :
- Diabetologia: Clinical, Translational and Experimental Diabetes and Metabolism. 64(2):313-324
-
Czasopismo naukowe